Tenax Therapeutics Inc.
TENX | NASDAQ
$1.94
+$0.06 (+3.19%)
At close: Sep 22, 2026, 4:00 PM ET
$1.94
$0 (0.00%)
After-hours:
Sep 22, 2026, 7:51 PM ET
Market Data
Market Cap $49.87M
Enterprise Value $-68.11M
Beta 0.93
Average Volume 3.59M
Shares Outstanding (Diluted) 50.87M
Shares Change YoY 28.55%
Institutional Ownership 46.93%
Exchange NASDAQ
ISIN US88032L6056
Price Performance
Price Change 1M 8.7%
Price Change 3M -86.2%
Price Change 6M -86.6%
Price Change YTD -83.0%
Price Change 1Y -70.8%
Price Change 3Y -91.8%
Price Change 5Y -99.9%
1M CAGR (ann.) -86.0%
1Y CAGR (ann.) -70.7%
5Y CAGR (ann.) -76.1%
All-Time CAGR -49.1%
Valuation
PE Ratio -1.26
Forward PE N/A
PEG Ratio 0.03
Forward PEG 2.36
PS Ratio N/A
Forward PS 3.90
PB Ratio 0.44
P/FCF Ratio -1.08
P/Adj. FCF Ratio -1.15
P/OCF Ratio -2.09
EV/Sales N/A
EV/EBIT 1.45
EV/EBITDA 1.45
EV/FCF 1.48
Earnings Yield -79.3%
FCF Yield -92.3%
Adj. FCF Yield -87.1%
Financial Health
Net Cash $117.98M
Total Debt $0
Cash & Short-Term Investments $117.98M
Total Assets $121.66M
Current Ratio 15.07
Quick Ratio 15.07
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage 0.00
Altman Z-Score -1.06
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -5.6%
Returns
Return on Assets -53.3%
Return on Equity -61.5%
Return on Invested Capital -60.4%
Return on Capital Employed -60.4%
Return on Tangible Assets -53.3%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y -54.5%
EPS CAGR 3Y 126.4%
EPS CAGR 5Y 84.5%
EPS CAGR 10Y 38.1%
FCF CAGR 3Y -67.1%
FCF CAGR 5Y -40.5%
FCF CAGR 10Y -16.3%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 9
EPS Growth Next 3Y -1.3%
Revenue Growth Next 3Y N/A
Earnings Date Nov 10, 2026
EPS Estimate (next Q) -$0.35
EPS Growth Est (next Q) -12.5%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $4.40
Price Target Upside 134.0%
Cash Flow
Operating Cash Flow $-46.03M
Free Cash Flow $-46.03M
Adj. Free Cash Flow $-43.45M
FCF Per Share -$0.90
OCF Per Share -$0.90
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $0
Operating Income $-49.83M
EBITDA $-47.06M
Net Income $-64.86M
EPS (Diluted) -$1.49
Revenue / Employee N/A
Profit / Employee $-4.32M
Employees 15
Add to Watchlist
Select watchlists to add or remove TENX